T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study

PURPOSE: Genetically engineered T-cell therapy is an emerging treatment of hematologic cancers with potential utility in epithelial cancers. We investigated T-cell therapy for the treatment of metastatic human papillomavirus (HPV)–associated epithelial cancers. METHODS: This phase I/II, single-cente...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Oncol
Hauptverfasser: Doran, Stacey L., Stevanović, Sanja, Adhikary, Sabina, Gartner, Jared J., Jia, Li, Kwong, Mei Li M., Faquin, William C., Hewitt, Stephen M., Sherry, Richard M., Yang, James C., Rosenberg, Steven A., Hinrichs, Christian S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Clinical Oncology 2019
Schlagworte:
ORIGINAL REPORTS
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6800280/
https://ncbi.nlm.nih.gov/pubmed/31408414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.02424
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge